Trestolone (MENT)
7-alpha-methyl-19-nortestosterone. Extremely potent 19-nor AAS. Can replace testosterone as a cycle base. Available as acetate ester.
Overview
7-alpha-methyl-19-nortestosterone. Extremely potent 19-nor AAS. Can replace testosterone as a cycle base. Available as acetate ester.
Very strong HPTA suppression, aromatises to 7-alpha-methyl-estradiol (not detected on standard E2 assays — use sensitive LC-MS/MS), significant lipid impact, may elevate prolactin (19-nor derivative), does not convert to DHT, highly anabolic
Compound Guide
Ester: Acetate (most common). Very short ester requiring daily or twice-daily injection. No-ester (TNE-style) formulations also exist.
Dosage:
- Low / TRT-replacement trial: 5-10mg/day (acetate)
- Enhancement: 10-25mg/day for 8-12 weeks
- Advanced: 25-50mg/day (significantly increases side effect risk)
Injection Protocol:
- Inject daily (acetate ester) — SubQ with insulin syringe is practical at these low volumes
- IM also viable: 27-30g needle, delts/VG
Key Notes:
- One of the most potent AAS by mg — effective doses are very low compared to testosterone
- Aromatises to 7-alpha-methyl-estradiol which does NOT show on standard E2 immunoassays — you must use LC-MS/MS estradiol testing to monitor
- Can serve as a testosterone replacement (maintains libido, mood, erectile function) but long-term safety data is limited
- 19-nor derivative: may elevate prolactin — have Cabergoline on hand
- No DHT conversion means less hair loss and prostate impact, but also no DHT-mediated neurological benefits
- Very suppressive to HPTA — aggressive PCT required
There is no pharmaceutical MENT, so everything is underground-lab product; how to test for contamination: How to test for heavy metals in UGL steroids and peptides.
Usage History
Pairs With
How Trestolone (MENT) behaves when it is run alongside other compounds.
Used to offset
Stacks the risk
Frequently Asked Questions
Quick Reference
Category
AAS
Half-Life
40 min (no ester) / 1-2 days (acetate)
Detection Time
Unknown (limited data)